3 models fit Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) and they disagree: 1 of 3 land within 15% of the average.
Two or more of our models back this value.
Large discount(i)Bronze51
Valued as a utility: P/E comparison, EV/EBITDA comparison, and Discounted cash flow.
ACCE opinionCompanhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) (SBS)
Fair value (3 models)
$9.21
ACCE price target
$8.00
Rating
Undervalued
Horizon
12 months
Fair value published on 20 Oct 2026, 16:04 CEST; previously $8.32 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 9 Oct 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 16:04 CEST.
Price used: $6.40 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
30.5% below
+43.9% to fair value
ACCE score
67
out of 100
Analysts
100% buy
6 covering
P/E
14.3x
forward 11.5x
1-year return
+31.4%
Dividend yield
0.53%
Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Sabesp, the privatized water and sewage utility serving the São Paulo metropolitan region, earns almost all its revenue from regulated water and wastewater tariffs billed to tens of millions of people, with the state's sanitation concession giving it a near-monopoly footprint in Brazil's largest economy. The structural case rests on that regulated base: the company converts a 31.5% operating margin and 18.8% ROE into cash under a tariff framework that resets with inflation, and after the 2024 privatization it operates under a new contract with large sewage-collection and treatment investment commitments that should expand the asset base and lift revenue. Reported revenue growth of 13.9% and a trailing P/E of 15.3 (15.6 forward) put the stock at a modest multiple for that growth, though forward estimates are not flat, so the forward P/E sitting slightly above trailing is worth reconciling in the model. The main thing to test is whether the capex program converts into regulated returns without a tariff or regulatory slippage, given Brazil's inflation and interest-rate path and the currency exposure embedded in an ADR priced in dollars. At $23.7B market cap with no index membership, the name is a candidate for a deeper look on earnings quality, capex funding, and tariff-reset mechanics rather than a conclusion on its own.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
high
Earnings collapse vs revenue growth
Earnings fell 33.9% YoY while revenue rose 13.9%. Operating margin of 31.5% masks deteriorating profitability; negative FCF of $6.3B signals cash burn despite top-line gains.
high
ACCE score collapse
Score dropped 20 points in 90 days (85 to 65). Growth component fell from implied strength to 40/100, indicating fundamental deterioration in model inputs.
moderate
Negative free cash flow
FCF of negative $6.3B on $23.7B market cap signals capital intensity or working capital stress. Unsustainable at current scale without external funding.
moderate
High leverage with earnings pressure
Debt/Equity of 1.14 combined with 33.9% earnings decline limits financial flexibility. Regulated utility status constrains pricing power to offset cost pressures.
AI research notes
AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 13.9% year over year, demonstrating strong demand for essential water and sanitation services.
Net margin of 19.7% and ROE of 18.8% show the company generates substantial profits from its capital base.
All six analysts rate the stock Buy or Strong Buy, with mean price target matching current price of $6.74.
Why it could disappoint
Free cash flow was negative BRL 6.3B over the last twelve months, raising questions about dividend sustainability.
Debt to equity of 1.14 is elevated for a utility, limiting financial flexibility for the mandated capex program.
Five year average revenue growth of only 0.2% per year suggests the recent 13.9% spike may not be sustainable.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 9, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where SBS's valuation models land
Price
$6.40
Model fair value
$9.21
Model range
$6.19 to $11.98
Fair value $9.21
Price $6.40
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
+Quarter-over-quarter institutional position changes
+Every insider and Congress trade, with how late it was disclosed
+Active 13D activist filings and top holders
Compare
Where it sits vs peers
News and Record
Press releases mentioning this company
Recent performance
1 week
+2.2%
1 month
+23.8%
3 months
+14.1%
6 months
-7.8%
YTD
+34.2%
1 year
+31.4%
SEC filings
Recommendation history, last 12 months
Date
Type
New
Previous
Price
20 Oct 2026, 16:04 CEST
Fair value
$9.21
$8.32
$6.30
20 Oct 2026, 16:04 CEST
Rating
Undervalued
first publication
$6.30
16 Oct 2026, 00:00 CEST
Fair value
$8.32
first publication
$6.42
9 Oct 2026, 00:00 CEST
ACCE price target
$8.00
first publication
$6.59
Price
+29.6% · 1Y
Ask anything about SBS
Answered from Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) fundamentals + recent valuations. Every number shows its source and date.
This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 14.3x14.3xhigh 26.3x
ROEbetter than 67% of peers
low 8%19%high 28%
Div yieldbetter than 0% of peers
low 0.5%0.5%high 3.9%
Peers
Prices Oct 23, 2026
Company
Price
Fair value
vs fair value
P/E
ROE
Quality
Score
SBSCompanhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares)